Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that interim data from the single center Phase III randomized MIRAGE trial, led by UCLA, comparing...
United States San Francisco Kishan Amarukishan Amar Kishan Prnewswire Viewray Inc American Society Of Clinical Oncology
Source: prnewswire.com